The alpha chain of the IL-2 receptor determines the species specificity of high-affinity IL-2 binding

被引:11
|
作者
Liu, KD
Greene, WC
Goldsmith, MA
机构
[1] UNIV CALIF SAN FRANCISCO,SCH MED,GLADSTONE INST VIROL & IMMUNOL,SAN FRANCISCO,CA 94141
[2] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MED,SAN FRANCISCO,CA 94143
[3] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143
关键词
human; interleukin; 2; ligand binding; lymphocyte; mouse;
D O I
10.1006/cyto.1996.0082
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin 2 (IL-2) mediated signalling results from ligand binding and subsequent heterodimerization of IL-2r beta and gamma(c). The high-affinity IL-2 receptor (IL-2r) is a heterotrimer comprised of the IL-2r alpha, IL-2r beta and gamma(c) subunits. Whereas human IL-2 effectively binds to either human or murine lymphocytes, murine IL-2 binds with markedly higher affinity to murine receptor complexes than to human complexes, Using cell lines stably expressing heterotrimeric IL-2r that vary in the species origin of individual subunits, we have demonstrated that IL-2r alpha is primarily responsible for the species specificity of IL-2 binding, Studies of ligand binding to the low affinity receptor demonstrated that IL-2r alpha displays a similar species preference to the heterotrimeric complex, Moreover, differences in ligand binding are reflected in differences in proliferation, A cell line expressing human IL-2r alpha and IL-2r beta along with murine gamma(c) vigorously proliferated only in response to human IL-2 at low doses, while both human and murine IL-2 stimulated proliferation of a cell line containing murine IL-2r alpha (as well as human IL-2r beta and murine gamma(c)). Therefore, IL-2r alpha is the chain primarily responsible for the species specificity of ligand binding. (C) 1996 Academic Press Limited
引用
收藏
页码:613 / 621
页数:9
相关论文
共 50 条
  • [41] STRUCTURE-FUNCTION-RELATIONSHIPS FOR IL-2 AND THE IL-2 RECEPTOR
    KUO, LM
    ROBB, RJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 78 - 78
  • [42] IL-1 INDUCES HIGH-AFFINITY IL-2 RECEPTOR EXPRESSION OF CD4-8- THYMOCYTES
    FALK, W
    MANNEL, DN
    DARJES, H
    KRAMMER, PH
    JOURNAL OF IMMUNOLOGY, 1989, 143 (02): : 513 - 517
  • [43] Neutralizing IL-2 antibodies enhance in vivo IL-2 activity by prolonging its half-life and reducing IL-2 binding to IL-2 receptor-expressing cells
    Bouchaud, G.
    Krieg, C.
    Boyman, O.
    ALLERGOLOGIE, 2011, 34 (02) : 100 - 100
  • [44] PROTEIN-PHOSPHORYLATION MEDIATED BY IL-2/IL-2 RECEPTOR BETA-CHAIN INTERACTION
    ISHII, T
    TAKESHITA, T
    NUMATA, N
    SUGAMURA, K
    JOURNAL OF IMMUNOLOGY, 1988, 141 (01): : 174 - 179
  • [45] Differential effects of IL-2 and IL-15 on expression of IL-2 receptor α
    Alileche, A
    Goldman, CK
    Waldmann, TA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 285 (05) : 1302 - 1308
  • [46] PSEUDO-HIGH AFFINITY INTERLEUKIN-2 (IL-2) RECEPTOR LACKS THE 3RD COMPONENT THAT IS ESSENTIAL FOR FUNCTIONAL IL-2 BINDING AND SIGNALING
    ARIMA, N
    KAMIO, M
    IMADA, K
    HORI, T
    HATTORI, T
    TSUDO, M
    OKUMA, M
    UCHIYAMA, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05): : 1265 - 1272
  • [47] Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription
    Meyer, WKH
    Reichenbach, P
    Schindler, U
    Soldaini, E
    Nabholz, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (50) : 31821 - 31828
  • [48] HIGH-AFFINITY IL-2 RECEPTORS ON A HODGKINS DERIVED CELL-LINE
    TESCH, H
    HERRMANN, T
    ABTS, H
    DIAMANTSTEIN, T
    DIEHL, V
    LEUKEMIA RESEARCH, 1990, 14 (11-12) : 953 - 960
  • [49] PRIMARY DETERMINATION ON RECEPTOR SUBUNIT BINDING ABILITY OF IL-2 MUTANTS BY IL-2 PARTIAL ANTAGONISTS
    WAN, FS
    NAN, GH
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 1995, 22 (04) : 374 - 376
  • [50] INTERLEUKINS (IL)-1 AND IL-2 CONTROL IL-2 RECEPTOR-ALPHA AND RECEPTOR-BETA EXPRESSION IN IMMATURE THYMOCYTES
    WILSON, A
    CORTHESY, P
    REICHENBACH, P
    MACDONALD, HR
    NABHOLZ, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (08) : 1729 - 1735